Literature DB >> 18562591

High rate of intestinal colonization with extended-spectrum-beta-lactamase-producing organisms in household contacts of infected community patients.

Aránzazu Valverde1, Fabio Grill, Teresa M Coque, Vicente Pintado, Fernando Baquero, Rafael Cantón, Javier Cobo.   

Abstract

Fecal carriage of extended-spectrum-beta-lactamase (ESBL)-producing organisms was detected in 70% of index cases of patients (n = 40) with community-acquired infections due to ESBL producers and reached 16.7% in household contacts (n = 54). A total of 66% of ESBL-producing organisms from index cases were indistinguishable from isolates from household contacts by pulsed-field gel electrophoresis. Patients with community infections and members of their households represent a reservoir for ESBL producers, increasing dispersal of resistance in healthy people.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18562591      PMCID: PMC2519510          DOI: 10.1128/JCM.01008-08

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  30 in total

1.  Rapid and simple determination of the Escherichia coli phylogenetic group.

Authors:  O Clermont; S Bonacorsi; E Bingen
Journal:  Appl Environ Microbiol       Date:  2000-10       Impact factor: 4.792

2.  Dramatic increase in prevalence of fecal carriage of extended-spectrum beta-lactamase-producing Enterobacteriaceae during nonoutbreak situations in Spain.

Authors:  Aránzazu Valverde; Teresa M Coque; M Paz Sánchez-Moreno; Azucena Rollán; Fernando Baquero; Rafael Cantón
Journal:  J Clin Microbiol       Date:  2004-10       Impact factor: 5.948

Review 3.  Emergence of Enterobacteriaceae producing extended-spectrum beta-lactamases (ESBLs) in the community.

Authors:  Johann D D Pitout; Patrice Nordmann; Kevin B Laupland; Laurent Poirel
Journal:  J Antimicrob Chemother       Date:  2005-05-25       Impact factor: 5.790

4.  Outbreak of multiply resistant enterobacteriaceae in an intensive care unit: epidemiology and risk factors for acquisition.

Authors:  J C Lucet; S Chevret; D Decré; D Vanjak; A Macrez; J P Bédos; M Wolff; B Regnier
Journal:  Clin Infect Dis       Date:  1996-03       Impact factor: 9.079

5.  Stool colonization with vancomycin-resistant enterococci in healthcare workers and their households.

Authors:  Joseph Baran; Jambunathan Ramanathan; Kathleen M Riederer; Riad Khatib
Journal:  Infect Control Hosp Epidemiol       Date:  2002-01       Impact factor: 3.254

6.  Epidemiology and successful control of a large outbreak due to Klebsiella pneumoniae producing extended-spectrum beta-lactamases.

Authors:  C Peña; M Pujol; C Ardanuy; A Ricart; R Pallares; J Liñares; J Ariza; F Gudiol
Journal:  Antimicrob Agents Chemother       Date:  1998-01       Impact factor: 5.191

Review 7.  Extended-spectrum beta-lactamases: a clinical update.

Authors:  David L Paterson; Robert A Bonomo
Journal:  Clin Microbiol Rev       Date:  2005-10       Impact factor: 26.132

Review 8.  Human intestinal bacteria as reservoirs for antibiotic resistance genes.

Authors:  Abigail A Salyers; Anamika Gupta; Yanping Wang
Journal:  Trends Microbiol       Date:  2004-09       Impact factor: 17.079

9.  Clinical and bacteriologic epidemiology of extended-spectrum beta-lactamase-producing strains of Klebsiella pneumoniae in a medical intensive care unit.

Authors:  D Decré; B Gachot; J C Lucet; G Arlet; E Bergogne-Bérézin; B Régnier
Journal:  Clin Infect Dis       Date:  1998-10       Impact factor: 9.079

10.  Is surveillance for multidrug-resistant enterobacteriaceae an effective infection control strategy in the absence of an outbreak?

Authors:  Michael A Gardam; Lori L Burrows; Julianne V Kus; James Brunton; Donald E Low; John M Conly; Atul Humar
Journal:  J Infect Dis       Date:  2002-11-14       Impact factor: 5.226

View more
  46 in total

1.  Characterization of fecal extended-spectrum-β-lactamase-producing Escherichia coli in a remote community during a long time period.

Authors:  Paul-Louis Woerther; Cécile Angebault; Hervé Jacquier; Olivier Clermont; Assyia El Mniai; Brigitte Moreau; Félix Djossou; Gilles Peroz; François Catzeflis; Erick Denamur; Antoine Andremont
Journal:  Antimicrob Agents Chemother       Date:  2013-08-05       Impact factor: 5.191

2.  Is fecal carriage of extended-spectrum-β-lactamase-producing Escherichia coli in urban rats a risk for public health?

Authors:  Sebastian Guenther; Julia Wuttke; Astrid Bethe; Jirí Vojtech; Katharina Schaufler; Torsten Semmler; Rainer G Ulrich; Lothar H Wieler; Christa Ewers
Journal:  Antimicrob Agents Chemother       Date:  2013-03-04       Impact factor: 5.191

3.  Spread of CTX-M-15 extended-spectrum β-lactamase-producing Escherichia coli isolates through household contact and plasmid transfer.

Authors:  Yasuko Kojima; Sohei Harada; Kotaro Aoki; Yoshikazu Ishii; Tomoka Sawa; Kei Hasegawa; Tsutomu Saji; Keizo Yamaguchi; Kazuhiro Tateda
Journal:  J Clin Microbiol       Date:  2014-02-19       Impact factor: 5.948

4.  blaNDM-1-producing Vibrio parahaemolyticus and V. vulnificus isolated from recreational beaches in Lagos, Nigeria.

Authors:  Abolade A Oyelade; Olawale Olufemi Adelowo; Obasola Ezekiel Fagade
Journal:  Environ Sci Pollut Res Int       Date:  2018-09-29       Impact factor: 4.223

5.  High rate of fecal carriage of extended-spectrum-β-lactamase-producing Escherichia coli in healthy children in Gipuzkoa, northern Spain.

Authors:  María Fernández-Reyes; Diego Vicente; María Gomariz; Olatz Esnal; Joseba Landa; Eider Oñate; Emilio Pérez-Trallero
Journal:  Antimicrob Agents Chemother       Date:  2014-01-06       Impact factor: 5.191

6.  Think (Gram) negative!

Authors:  Benedikt Huttner; Stephan Harbarth
Journal:  Crit Care       Date:  2010-06-25       Impact factor: 9.097

7.  Impact of outpatient antibiotic use on carriage of ampicillin-resistant Escherichia coli.

Authors:  Matthew H Samore; Claude Tonnerre; Elizabeth Lyon Hannah; Gregory J Stoddard; Robert J Borotkanics; Bassam Haddadin; Stephan Harbarth
Journal:  Antimicrob Agents Chemother       Date:  2010-11-29       Impact factor: 5.191

8.  Phylogenetic distribution of CTX-M- and non-extended-spectrum-β-lactamase-producing Escherichia coli isolates: group B2 isolates, except clone ST131, rarely produce CTX-M enzymes.

Authors:  Sylvain Brisse; Laure Diancourt; Cédric Laouénan; Marie Vigan; Valérie Caro; Guillaume Arlet; Laurence Drieux; Véronique Leflon-Guibout; France Mentré; Vincent Jarlier; Marie-Hélène Nicolas-Chanoine
Journal:  J Clin Microbiol       Date:  2012-07-03       Impact factor: 5.948

Review 9.  Trends in human fecal carriage of extended-spectrum β-lactamases in the community: toward the globalization of CTX-M.

Authors:  Paul-Louis Woerther; Charles Burdet; Elisabeth Chachaty; Antoine Andremont
Journal:  Clin Microbiol Rev       Date:  2013-10       Impact factor: 26.132

10.  Spread of bla(CTX-M-14) is driven mainly by IncK plasmids disseminated among Escherichia coli phylogroups A, B1, and D in Spain.

Authors:  Aránzazu Valverde; Rafael Cantón; M Pilar Garcillán-Barcia; Angela Novais; Juan Carlos Galán; Andrés Alvarado; Fernando de la Cruz; Fernando Baquero; Teresa M Coque
Journal:  Antimicrob Agents Chemother       Date:  2009-09-28       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.